News

TB R&D Weekly Update: Tuberculosis and Cancer

A Dowsett, Health Protection Agency/Science Photo Library

Vento S, Lanzafame M. Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol. 2011 Jun;12(6):520-2.

This week we review a commentary on the correlations between tuberculosis and cancer, specifically lung cancer. There are three major questions that Vento & Lanzafame seek to answer in the article:

  1. How can TB promote lung cancer?
  2. Does cancer promote tuberculosis reactivation?
  3. HIV infection is associated with increase lung cancer cases., can TB further increase this risk?

For question number one, the explanation given centers around the factor involved in the inflammation and fibrosis that occurs in the lung during TB disease. The factors that control TB infection (TNF-α) can promote tumor survival and tumor initiation.

To answer the second question, the authors cite studies by Wu, et al., that showed cancers of the aerodigestive tract and hematological cancers are significant risk factors for TB.

The complexity of the relationship between tuberculosis and cancer is apparent when it comes to diagnosis. The author points to a few aspects to consider for diagnosis:

  1. Cancer should be suspected if there are changes (whether symptomatic or radiographical) in a patient after months or years after TB infection.
  2. Every effort should be made to check for TB when cancer is diagnosed to initiate TB treatment.
  3. In developing countries, TB is often suspected over cancer creating delays in diagnosis of cancer. The symptoms of TB and lung cancer are very similar.

Finally, the answer to question three seems to be “no”. A study by Shebl, et al. showed that lung cancer risk over 10 years was unrelated to TB in patients with AIDS diagnosis.

Additional links to TB R&D News:

The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy

Slowing the spread of drug-resistant diseases is goal of new research area

Antibiotic Incentive Bill Reintroduced: Industry Hopes for 2012 Enactment

More News
19 Mar 2024
For World TB Day 2024, the WGND is spotlighting a monumental achievement in TB drug research and development: the Global TB Drug Pipeline has never been bigger than it is today. The number of drug candidates being clinically evaluated for use in the treatment of adult pulmonary TB has surpassed...
3 Aug 2023
The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, is co-hosting a New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting will be...
23 Aug 2022
The PAN-TB collaboration announced initial plans for a Phase 2 clinical trial evaluating two novel drug regimens to treat Tuberculosis. Sponsored by the Bill and Melinda Gates Foundation, the PAN-TB, or “Project to Accelerate New Treatments for Tuberculosis”, collaboration brings together non-...